Yun, S., Sim, E., Han, S., Kim, T., Ju, M., Han, J., . . . Park, J. (2017). In vitro and in vivo anti-leukemic effects of cladoloside C(2) are mediated by activation of Fas/ceramide synthase 6/p38 kinase/c-Jun NH(2)-terminal kinase/caspase-8. Oncotarget.

Yun, Seong-Hoon, et al. "In Vitro and in Vivo Anti-leukemic Effects of Cladoloside C(2) Are Mediated By Activation of Fas/ceramide Synthase 6/p38 Kinase/c-Jun NH(2)-terminal Kinase/caspase-8." Oncotarget 2017.

Yun, Seong-Hoon, et al. "In Vitro and in Vivo Anti-leukemic Effects of Cladoloside C(2) Are Mediated By Activation of Fas/ceramide Synthase 6/p38 Kinase/c-Jun NH(2)-terminal Kinase/caspase-8." Oncotarget 2017.